Triple Negative Breast Cancer (TNBC) is an aggressive and metastatic phenotype of breast cancer, which is clinically negative for estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2) receptors1. This evidence concerns the gene ERBB2 and breast cancer.